9003 ORAL Biomarker Analysis in BO21015, a Phase II Randomised Study of First-line Bevacizumab (BEV) Combined With Carboplatin-gemcitabine (CG) or Carboplatin-paclitaxel (CP) in Patients (pts) With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer (NSCLC)

Saved in:

Bibliographic Details
Published in:	European journal of cancer (1990) Vol. 47; p. S592
Main Authors:	Mok, T, Gorbunova, V, Juhasz, E, Szima, B, Burdaeva, O, Yu, C.J, Delmar, P, Pallaud, C, Jonnaert, M, Reck, M
Format:	Journal Article
Language:	English
Published:	Elsevier Ltd 2011
Subjects:	Hematology, Oncology and Palliative Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0959-8049 1879-0852
DOI:	10.1016/S0959-8049(11)72315-2